MB, Levis & Associates’s iShares iBonds Dec 2036 Term Corporate ETF IBCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.5M Buy
782,135
+231,022
+42% +$5.66M 6.78% 3
2026
Q2
$13.9M Buy
+551,113
New +$13.8M 5.11% 7

Other funds holding IBCB

MB, Levis & Associates's IBCB Position: Q3 2026 in Review

MB, Levis & Associates increased its iShares iBonds Dec 2036 Term Corporate ETF (IBCB) stake by 42% in Q3 2026, buying an estimated $5.66M and bringing the position to 782,135 shares worth $18.5M. The position accounts for 6.78% of the portfolio, ranked #3.

MB, Levis & Associates first reported a position in IBCB in Q2 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold IBCB as of Q3 2026.

  • MB, Levis & Associates held 782,135 shares of iShares iBonds Dec 2036 Term Corporate ETF worth $18.5M as of Q3 2026.
  • MB, Levis & Associates bought 231,022 iShares iBonds Dec 2036 Term Corporate ETF shares in Q3 2026, an estimated $5.66M.
  • iShares iBonds Dec 2036 Term Corporate ETF made up 6.78% of MB, Levis & Associates's portfolio in Q3 2026, its #3 holding.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2036 Term Corporate ETF in Q2 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held iShares iBonds Dec 2036 Term Corporate ETF as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.